An eight-lot open procedure contract covering ready-to-use culture media for microbiology diagnostics in Berlin signals a structured, multi-category procurement approach from one of Germany’s largest clinical laboratory networks.

Create a free account and see the full public tender details here: https://app.hermix.com/opportunities/00112388-2026

Labor Berlin Charite Vivantes GmbH is one of Germany’s most significant clinical laboratory operations, providing diagnostic services across Berlin’s Charite and Vivantes hospital network. The organization now requires a comprehensive supply of microbiological culture media across eight distinct diagnostic categories, with a combined estimated value of €1,811,153 and a 24-month contract term.

The tender was published on 17 February 2026 via TED, with a submission deadline of 16 March 2026. For life science and laboratory supplies companies active in the German market, this is a focused, time-sensitive opportunity with clear product scope and structured lot architecture.

Opportunity Overview

Contracting Authority: Labor Berlin Charite Vivantes GmbH / Labor Berlin Charite Vivantes Services GmbH
Reference Number: Labor Berlin 4_2025
Document ID: 00112388-2026
Tender Title: Tender for Culture Media in the Field of Microbiology (Ausschreibung von Nährmedien im Fachbereich Mikrobiologie)
Scope of Work: Supply of ready-to-use microbiological culture media across eight product categories for clinical diagnostic use, covering variable diagnostics, chromogenic media, broths, Candida detection, enteritis diagnostics, resistance testing, selective media, and VRE screening.

Lot Structure:

• Lot 1: Culture Media for Varia-Diagnostics (Columbia Blood Agar, MacConkey Agar, Chocolate Agar variants, Schaedler Agar) – maximum ceiling €1,740,000 net
• Lot 2: Chromogenic Culture Media (ESBL, uropathogenic bacteria, MRSA detection) – maximum ceiling €1,720,000 net
• Lot 3: Broths (Thioglycolate Broth, Sabouraud Broth) – maximum ceiling €200,000 net
• Lot 4: Chromogenic Culture Medium for Candida spp. – maximum ceiling €128,000 net
• Lot 5: Culture Media for Enteritis Diagnostics (Campylobacter, Salmonella-Shigella, Yersinia CIN, XLD Agar) – maximum ceiling €88,000 net
• Lot 6: Culture Media for Resistance Testing (Mueller Hinton II, Mueller Hinton Fastidious Agar) – maximum ceiling €168,000 net
• Lot 7: Selective Culture Media (Burkholderia cepacia Agar, Streptococcus Group B Agar, Clostridium difficile Agar) – maximum ceiling €96,000 net
• Lot 8: Chromogenic Selective Agar VRE (vancomycin-resistant Enterococci) – maximum ceiling €248,000 net

Location / Place of Performance: Berlin, Germany
Estimated Total Value: €1,811,153
Contract Duration: 24 months
Procedure Type: Open
Award Criteria: Quality and Price (all lots)
Publication Date: 17/02/2026
Deadline:16/03/2026
Tender Opening Date: 16/03/2026
Language Requirements: German only
EU Funding: No
Contact:ausschreibung@laborberlin.com / +49 30405026800
Submission Portal: http://www.deutsche-evergabe.de/dashboards/dashboard_off/9722202c-ffa9-4e86-bc40-d7613d8a225c

Ready to qualify tenders like this faster?

Create your free Hermix account at https://hermix.com/sign-up/ and access AI-powered tender analysis, competitive intelligence, and automated monitoring across Europe’s €2 trillion public procurement market.

Authority and History

Labor Berlin Charite Vivantes is a body governed by public law, classified under health as its main activity. It operates as the central laboratory provider for two of Berlin’s largest hospital groups: Charite Universitaetsmedizin Berlin and Vivantes Netzwerk fuer Gesundheit GmbH. This institutional background makes it one of the highest-volume clinical diagnostic entities in Germany, processing laboratory analyses at a scale that demands consistent, high-quality reagent and culture media supply.

The authority’s procurement context within the Hermix platform shows 25 all contract awards totaling €60 million, of which 17 similar contract awards account for €57 million. On the renewal side, 15 all renewals are valued at €60 million, with 9 similar renewals reaching €57 million. There are currently no similar open tenders and no all open tenders active. One similar prior notice is listed, though it carries no stated value.

The pipeline picture is notable. The high alignment between similar contract awards (€57M) and similar renewals (€57M) suggests that this category of procurement recurs consistently. For suppliers, that signals long-term commercial relevance: a win here is likely to convert into renewal discussions within the 24-month contract window. Additionally, over 10,000 other buyers across Europe hold similar projects totaling €3.4 billion, confirming that this product category is a broadly active procurement segment.

Competitive Landscape

The Winners of Similar Contracts table (data limited to 10 results) shows a field dominated by large, established life science and diagnostics multinationals. The breakdown is as follows:

• Becton Dickinson: €4M across 4 contracts, averaging €1M per contract
• Thermo Fisher Scientific: €0.2 across 3 contracts, averaging €0.1 per contract
• Sysmex: €400K across 2 contracts, averaging €200K per contract
• Siemens: €150K across 2 contracts, averaging €75K per contract
• Bruker Daltonics KG: €2 across 2 contracts, averaging €1 per contract
• Qiagen: 1 contract (value not stated in the PDF)
• Roche: €50M across 1 contract, averaging €50M per contract
• Immunodiagnostic Systems Deutschland: €2M across 1 contract, averaging €2M per contract
• Ortho Clinical Diagnostics: €1 across 1 contract, averaging €1 per contract

Roche commands the most striking single-contract value at €50M for one award, suggesting that at least one very large aggregated or multi-year laboratory supply agreement has been awarded in this space. Becton Dickinson holds the highest contract frequency among the listed competitors, with four awards and an average of €1M each. Together, these two companies represent the clearest pattern of market concentration at the top.

Thermo Fisher Scientific’s presence with three contracts is notable, as it is a direct competitor to Becton Dickinson for microbiological and diagnostic reagent supply. The remaining contractors each hold one or two contracts and operate at significantly smaller values, suggesting a secondary tier of more specialist or regional suppliers.

The Contractors’ Countries table shows Germany as the sole listed country for the awarded contracts in this category: 17 contracts totaling €57M, with an average value of €3.8M. This is a strongly Germany-concentrated market, at least as reflected in the similar contract dataset. It points to procurement patterns where local or German-registered entities with established distribution infrastructure have been the primary winners.

Commercial and Procedural Signals

Award Criteria: Quality and Price apply uniformly across all eight lots. No specific weighting is stated in the PDF. Bidders should expect a balance between technical product quality documentation and competitive pricing, rather than a pure price race.

Procedure Type: The open procedure places this tender in the publicly accessible, non-restricted category. Any eligible supplier may submit. There is no prior qualification stage, which lowers the entry barrier but also means competition could be broad.

Language: German is the sole permitted language for submissions. This is a meaningful constraint. Non-German-speaking organizations, or those without German-language bid preparation capacity, will face practical difficulty submitting a compliant offer. It effectively limits realistic competition to German-registered entities or international companies with established German operations and German-language documentation capability.

Lot Strategy: Eight distinct lots allow suppliers to bid on individual product categories without committing to the full supply scope. A specialist in chromogenic media, for example, can target Lots 2 and 4 independently. This structure favors both broad-line distributors and focused specialists, making lot selection a key strategic decision.

Contract Duration: 24 months is a straightforward, mid-length supply agreement. No extension options are stated in the PDF. Suppliers should model pricing and logistics on a fixed two-year horizon.

Submission Timeline: From publication on 17 February 2026 to the deadline on 16 March 2026 is 27 days. This is a tight window. Organizations that are not already monitoring this tender category will have limited time to prepare a compliant German-language submission with full technical product documentation across their selected lots.

EU Funding: Not applicable. Standard German public procurement rules govern this procedure.

Narrative Insight

The €1.81 million value distributed across eight lots paints a picture of a high-specificity, operationally critical procurement. Labor Berlin Charite Vivantes is not buying generic laboratory consumables. It is procuring a defined set of culture media formulations tied directly to clinical diagnostic protocols, from Clostridium difficile selective agar to VRE screening media. Each lot corresponds to a specific diagnostic function, which means substitution with non-equivalent products is not realistic. Suppliers who can demonstrate product equivalence or superiority in quality documentation will carry a real advantage.

The complete concentration of awarded contracts in Germany, at €57M across 17 awards with an average of €3.8M, reflects both the product category and the purchasing authority’s likely expectations. This is not a market where cross-border entrants without German distribution infrastructure have historically captured awards, based on the data available in the PDF.

Roche’s single contract at €50M stands out. It suggests that in this sector, framework agreements with very large clinical laboratory operators can consolidate into a single high-value relationship. That does not necessarily describe the current tender, which is structured as eight separate lots. But it does indicate the long-term commercial ceiling for a supplier that builds a trusted relationship with an authority of Labor Berlin’s scale.

Hermix users analyzing this tender can access this competitive intelligence instantly, including detailed contractor profiles, authority spending patterns, and the full renewal pipeline, in minutes rather than hours.

The renewal data is arguably the most strategically important context here. Nine similar renewals totaling €57 million indicate that the broader market for this product category is cycling regularly. A supplier who wins one or more lots in this tender is entering a procurement relationship with high renewal probability, not a one-off transaction.

Practical Takeaways for Bidders

Who this tender suits:

• Life science and diagnostics companies with established German operations and German-language bid preparation capacity, given the German-only language requirement
• Microbiological culture media manufacturers or distributors who can supply specific branded or equivalent formulations matching the technical specifications per lot
• Broad-line laboratory supply companies capable of competing across multiple lots simultaneously, particularly Lots 1, 2, and 8, which carry the highest individual lot ceilings
• Specialist suppliers focused on chromogenic or selective media who can target individual lots without needing to compete across the full scope

Critical attention points:

• The 27-day window from publication to deadline (17 February to 16 March 2026) demands immediate mobilization. German-language technical documentation and pricing must be prepared urgently
• German is the only permitted language for offers. This is a hard compliance requirement, not a preference. Non-compliant language submissions will be disqualified
• Each lot has a defined maximum spending ceiling (Höchstgrenze). These are upper limits, not guaranteed volumes. Pricing strategy must account for variable call-off quantities
• Award criteria combine Quality and Price for all lots. Technical product sheets, quality certifications, and equivalence documentation will carry real evaluation weight alongside price
• The submission portal is the deutsche-evergabe.de platform. Registration and submission must be completed through this system before the 16 March 2026 deadline
• Lot 1 (€1,740,000 ceiling) and Lot 2 (€1,720,000 ceiling) represent by far the largest individual opportunities. Suppliers with broad product portfolios covering multiple agar types should prioritize these two lots while assessing the smaller specialist lots for complementary bidding

Labor Berlin Charite Vivantes is a structurally important buyer in Germany’s clinical laboratory supply market, with a procurement history showing €57 million in similar contract awards and a renewal pipeline of equal scale. This eight-lot tender for microbiological culture media, valued at €1.81 million over 24 months, sits within a category where a small number of established German-market players have historically dominated. The German-only language requirement and the 27-day submission window make early qualification analysis essential. Data-driven market intelligence shortens that analysis from days to hours, helping suppliers identify which lots suit their product portfolio and where they face the strongest competition.

Create your free account today at https://hermix.com/sign-up/ and win more public contracts with the data-driven approach that helps companies consistently succeed in B2G sales across Europe.